Mortality associated with delay in operation after hip fracture
Scottish data provide additional information . . .
Editor-Bottle and Aylin's study provides evidence of an association between delay to hip fracture surgery and mortality, 1 a topic that has proved controversial.
2 However, as their analysis depended on routinely collected data, the study had important limitations. Scottish data provide additional relevant information.
Scottish hip fracture audit data are collected prospectively, 3 and records have been linked to routinely collected data for hospital admissions and mortality. 4 We studied one year mortality in patients undergoing hip fracture surgery between 1998 and 2003, in groups of patients stratified by the reason for delay to surgery (n = 8470). We used Cox proportional hazards regression analysis to adjust for potential confounding factors including age, sex, hospital, and residence before the fracture; American Society of Anesthesiologists' grade (a measure of systemic illness before fracture); and number and type of hospital admissions in the five years before the hip fracture.
Surgery was delayed by more than 24 hours after hospital admission in 3364 (40%) patients, of which 1432 operations (43%) were delayed for administrative reasons including restricted access to theatre, surgeon, or anaesthetist; 1315 people (39%) were initially medically unfit for surgery and 617 operations (18%) were delayed for other reasons. Overall, 2531 (30%) patients died in the year after admission for hip fracture. Compared with patients operated on within 24 hours, delay to surgery in patients who were initially medically unfit was associated with increased mortality (hazard ratio 1.3; 95% confidence interval 1.1 to 1.4). However, there was no evidence of an association between delay to surgery and mortality for patients whose operation was delayed for administrative reasons (hazard ratio 0.9, 95% confidence interval 0.8 to 1.0) or for other reasons (1.1, 0.9 to 1.2).
These Scottish data support an association between delay to surgery and mortality after hip fracture, and show that the association persisted for at least a year after admission for hip fracture. However, the excess mortality seems only to be present when the delay was for medical reasons. 
. . . but Italian data seem to contradict study findings
Editor-In contrast to Bottle and Aylin, 1 we found that delayed surgery alone seems not to increase mortality after hip fracture after adjustment for comorbidity, age and sex, and taking hospital level variability into account.
We examined data from regional hospital discharge registers in Friuli Venezia Giulia, a region in northeastern Italy (population 1 200 000), where each year more than 2200 elderly people are admitted for hip fracture. We selected all patients aged 65 and older with a main diagnosis of hip fracture that was surgically treated during 1996-2005, excluding patients with malignant neoplasm. In cases of multiple hip fracture we included only the first episode.
We considered all diagnoses coded in the hospital discharge records and in those of the previous year, calculating the Charlson comorbidity index for each patient 2 and dichotomising it such that 1 indicated presence of comorbidity and 0 absence. We dichotomised the waiting time for surgery by following the clinical indication in the medical literature (1 indicated immediate surgical treatment (same day or one day after admission) and 2 delayed surgical treatment (two days or more after admission)). We included the year in which the fracture occurred in the multivariate models to evaluate changing trends in mortality, after controlling for case mix of patients, and modelled this as a continuous variable. We estimated non-conditional logistic regression models and several multilevel logistical models to take into account hospital level variability. [3] [4] [5] We used a logistic regression model with robust variance estimates (Hubner/White/sandwich estimator) specifying hospitals as a cluster variable to obtain confidence intervals for the odds ratio adjusted for intraclass correlation. Confidence intervals were provided. We used Stata 7.0 for analysis.
In all, 13 822 patients were included, 4.7% of them dying in hospital. Bivariate analysis showed a significant association between mortality and age, male sex, comorbidity, and delayed surgery and a decrease in mortality from 1996 to 2005. Multilevel models showed no significant association between delayed surgery and increasing in-hospital mortality (odds ratio 1.18, 95% confidence interval 0.84 to 1.65). Comorbidity, male sex, and advanced age were associated with increased mortality in hospital and after discharge in all estimated models. Between 1996 and 2005 mortality decreased significantly.
Panic disorder: propranolol and behavioural therapy
Editor-Barr Taylor clearly shows that selective serotonin reuptake inhibitors (SSRIs) are well accepted as first line treatment for panic disorder.
1 However, many patients are still prescribed propranolol along with diazepam as first line treatment in primary care trusts to treat the adrenergic symptoms of panic disorder-such as palpitations, etc-although blockers have no proved efficacy in the treatment of panic disorder.
Considering patients' choice of treatments, many patients are generally quite keen on non-pharmacological methods such as cognitive behaviour therapy, especially after they consider the side effect profile of SSRIs. But if we consider the cost implications, one year's treatment with an SSRI-for example, paroxetine 20 mg-costs an estimated £289, including direct and indirect prescribing and including follow-up costs, which is around £10 more or less than other generic drugs. However, 16 one hour sessions of cognitive behaviour therapy delivered by a clinical psychologist cost an estimated £1056. That is more than £300 extra expenditure per patient per year.
2 In addition, the waiting lists of psychology departments are sometimes long.
Thus it is yet to be answered which is the most cost effective treatment for panic disorder, and only more thorough randomised controlled trials with patients receiving SSRIs and cognitive behaviour therapy can answer that. 
Manjeestha Das

Preterm delivery in primiparous women at low risk
Preterm birth or delivery? Study authors suggest new terms
Editor-The term preterm birth is used differently in the literature: some use preterm birth to refer to the number of infants born before 37 completed weeks, 1 2 and others use the term to specify the number of pregnancies ending before 37 completed weeks. 3 Still others have restricted their analyses to singleton pregnancies to avoid this difference. 4 The use of the alternative term preterm delivery varies in a similar fashion.
We noticed this difference in our study looking at infants born preterm and pregnancies ending preterm in Danish national data from 1995-2004 (22 April, pp 937-9). We found that the national proportion of preterm infants rose from 5.8% (4019/ 69 013) in 1995 to 7.2% (4650/64 223) in 2004; an increase of 24%. However, when mothers or pregnancies were counted, the proportions were 5.2% (3509/67 840) in 1995 and 6.3% (3975/62 814) in 2004, an increase of 22%. This discrepancy can easily be explained, as the proportion of twin gestations rose from 1.7% to 2.3% of all gestations during this 10 year period.
We often asked ourselves: "Does a twin pregnancy that ends at 32 weeks count as one or two preterm births?" From the obstetrician's point of view this is most likely to be one preterm birth but from a paediatric point of view, two. The quality of the data collected for many national registers and studies makes it possible to make this distinction. To compare such data over time, as well as between populations, it is important that agreement on the definitions of these terms be reached, especially at a time when the proportion of twin pregnancies is increasing. The importance of identical international definitions in perinatal health is a precondition for evaluation of differences in outcomes between populations and has already been recognised in the PERISTAT project. 5 We therefore propose two different, new, and distinguishable definitions: a preterm ending pregnancy ends before 37 completed weeks, and a preterm born infant is born before 37 completed weeks. A twin pregnancy delivered at 32 weeks will therefore be counted as one preterm ending pregnancy but as two preterm born infants.
Could epidemic chlamydia contribute to rise in preterm births?
Editor-The rise in preterm births described in Denmark would give cause for concern, in terms of long term health consequences, in any country.
1 One risk factor that is not described in this study is infection with chlamydia, 2 which is rising rapidly among young women in urban areas of the United Kingdom.
Given that most affected patients are unaware of their infection, and that specialist screening and treatment facilities are not easily accessible for most populations, could this be the "invisible" factor driving higher rates of premature babies, among "low risk" mothers? 
Is any involvement with the UK military unethical?
Editor-There are good ethical arguments for UK military staff to now refuse to participate in the military involvement in Iraq, as highlighted by the case of Kendall-Smith.
1
But are there major ethical problems with any association with the British military? Its possession of nuclear weapons and its failure to make substantive progress phasing these out, 2 despite disarmament being legally required by Article VI of the Nuclear Non-Proliferation Treaty (NPT), begs this question. Such a requirement has also been reinforced by the International Court of Justice ruling on the illegality of using nuclear weapons. Indeed, there are concerns that rather than disarming, the UK prime minister favours building a new generation of nuclear weapons to replace the Trident system. 3 The Mutual Defence Agreement (MDA) between the United States and the United Kingdom can be considered to support nuclear proliferation by facilitating UK weapons development. Furthermore, a legal opinion from respected UK lawyers has concluded that: "In our view, it is strongly arguable that the renewal of the MDA is in breach of the NPT." 4 With the world facing such critical issues such as climate change, environmental damage, and poverty, are the huge sums involved 
Compensation and complaints in New Zealand
Editor-In New Zealand complaints about quality of care are resolved independently from claims for compensation. The New Zealand Health and Disability Commissioner does not serve as a "gateway" to the no-fault compensation system. Separate and independent processes are available for responding to patients' nonmonetary interests (such as the desire for an apology, an explanation, or corrective action to prevent harm to future patients). 3 In particular, the Health and Disability Commissioner resolves complaints by advocacy, investigation, or mediation. 4 The commissioner's focus is on opening channels of communication between the doctor and patient, understanding what went wrong and why, and supporting doctors and healthcare organisations back into safe practice. The process is confidential, though the commissioner's findings are widely disseminated in an anonymised form so that lessons can be learnt from the adverse event.
Of course, some injured patients seek monetary and non-monetary remedies and may choose both to lodge a complaint and to file a no-fault compensation claim. 
Policing of information from internet breast cancer list
Findings may not be generally applicable
Editor-The article by Esquivel et al is misleading in some respects.
1 Their findings result from internet correspondence between individuals about a common condition that is given a lot of webspace and media attention.
My own (anecdotal) experience shows that a vast amount of ignorance remains when rarer conditions are considered. Between 2001 and 2003 I attempted to recruit women with hypoadrenalism for a study looking into adrenal hormone replacement. As this condition is very rare, I resorted to advertising for subjects on two websites, those of self help groups for hypoadrenalism (after this had been approved by the ethics committee).
I managed to recruit sufficient numbers for the study but kept myself enrolled to check on progress among my volunteers until mid-2005. I was surprised to see the depth of inaccuracy and distinct lack of knowledge among the people who posted on the sites. I refused to be drawn into discussions, as I would have ended up being the group doctor, which I had no intention of becoming. The one person on those sites who seemed to be giving the most information was a laboratory technician whose wife had hypoadrenalism.
Furthermore, from personal experience and that of my colleagues, the ever increasing band of "informed" patients who come to clinic armed with items they "found on the web," that vary from wildly inaccurate to frankly amusing, shows that many people refer to the web, but that an awful lot of nonsense is to be found there.
I have no problem with tackling the fears and questions of concerned patients, but when having to contradict the perceived wisdom of the all powerful internet, I wonder whether this is yet another reason to consider early retirement. 
"List mining" raises new issues in research ethics
Editor-"List mining" can be defined as the use, for research purposes, of messages sent to internet based mailing lists. The ethical questions raised by list mining are especially important for health related lists. For example:
x Should the people who were the original sources of messages sent to such lists properly be regarded as "research subjects"? This perspective raises questions pertaining to privacy, informed consent, whether the research is intrusive and has potential for harm, and whether the list should be perceived as "private" or "public" space x Should they be regarded as "published authors"? Although most participants may not even regard themselves as "amateur authors," issues of copyright and proper attribution are to be considered if messages sent to such lists are cited verbatim x Should they be regarded as "members of a community"? If so, how best to deal with individuals in such communities whose messages may need to be examined critically because they might endanger public health? Fortunately, the article by Esquivel et al provides evidence that, on the breast cancer mailing list, self policing works. 
The cause for quiet celebration
Editor-Perhaps we can help put Robert Jacoby and the dozen other men who found our editorial distressing out of at least a little of their misery?
1 2
The reason for the quiet celebration we suggest is that it has generally only been in extremely poor countries that women have died earlier than men in recent decades. By 2006 almost nowhere in the world seems so absolutely poor (at least in this sense) that this continues to be the case. We perhaps should have been clearer in what we wrote-but then no woman seems to have misunderstood the cause for quiet celebration, at least none who has responded to the editorial. Whether the United States has a "federally funded Office of Women's Health" (which seems to exercise Jacoby) is immaterial as to whether slightly fewer women in the poorest countries in the world now die than used to, often while delivering their (and their partner's) baby.
